We know everyone has a different experience with IBD every day. That’s why we are setting out to find a better treatment that will work for your specific Crohn’s or colitis. We believe that our state-of-the-art method for studying your genome and microbiome, together with your symptoms and lifestyle choices over an extended period of time, will help to bring us closer to a cure for IBD.*
IBD is different for everyone, so the more people we study, the more likely we are to discover new, meaningful connections. As part of this study, we are collecting both biological samples (stool and saliva) and digital lifestyle and health data from some 10,000 people. This study will take place in phases, with phase 1 numbering 50 to 100 participants. We’d love for you to participate in phase 1 and it’s completely free to you (usually a $500 to $2,000 value).
What’s in it for you:
How it works:
What will happen to your digital and biological data:
Who can participate
in the program:
You must have inflammatory bowel disease and live in the United States to participate.
If you reside outside the United States, please join our international waitlist and we’ll be in touch as soon as the program is available in your country.
You must be willing to provide stool and saliva samples and track your health using the Gali app, as well as to sign a consent form.
Ready to join us?
Please fill out the form below and we’ll reach out to you via email.
Thanks for your interest in our study. We will be in touch with the next steps shortly!
How you experience IBD is thought to be due to a combination of factors including your genes, the microorganisms in your gut (the microbiome), and environmental factors.
In individuals with IBD, there is evidence for an association between gut inflammation and the microbiome.
There is also evidence for differences in the microbiome between people who respond to certain treatments and those who do not.